FDA advisors back female sexual disorder drug
June 5, 2015Medical Communications, Research and Development, Sales and Marketing
An FDA advisory panel has backed a new drug intended to boost female sex drive, but warned that it must …
Google advances health data collection initiative
June 5, 2015Medical Communications, Sales and Marketing Apple, brett wells, google, healthkit, researchkit, studykit
Google is advancing a suite of applications known as ‘Study Kit’ that enable users to collect and share health information …
inVentiv Health appoints industry veteran
June 5, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Michael McKelvey, inVentiv Health
inVentiv Health has appointed Michael McKelvey as the president of its health clinical division and executive vice president. McKelvey is …
NICE U-turn on Janssen arthritis drug
June 4, 2015Sales and Marketing Janssen, NICE, Stelara, psoriasis, uturn
NICE has performed a U-turn on Janssen’s Stelara and has now recommended the drug for the treatment of psoriatic arthritis. …
Amgen and Novartis tussle over biosimilar injunction
June 4, 2015Sales and Marketing Amgen, FDA, Neupogen, Novartis
Novartis has begun its court battle with Amgen over its biosimilar of cancer drug Neupogen, which Amgen is trying to …
FDA to assess female libido drug
June 4, 2015Sales and Marketing FDA, Sprout Pharmaceutical, flibanserin, libido
The FDA is inching closer to a historic approval of a drug in the US commonly dubbed ‘Viagra for women’. …
Astellas spending $760m on autoimmune tie-up
June 4, 2015Sales and Marketing Astellas, anokion, brett wells, kanyos
Astellas Pharma and Anokion are to collaborate and develop new treatments for type 1 diabetes and celiac disease in a deal that could net …
Creabilis appoints board chairman
June 4, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Catherine Moukheibiras, creabilis
UK, Canterbury-based dermatology firm Creabilis has appointed Catherine Moukheibiras as the chairman of its board of directors. After an initial career in strategy …
Featured Interview on Industrial Design of Auto Injectors
June 4, 2015Sales and Marketing auto injectors, ondrugdelivery, shl group
The necessity for auto injector has been growing rapidly over the years, spurring a variety of innovative designs to meet …
Shire earns EMA nod for constipation drug
June 3, 2015Sales and Marketing EMA, Resolor, Shire, constipation
Shire has seen approval from the European Medicines Agency to extend the licence of its constipation drug Resolor for men …
Merck tests new Keytruda combination
June 3, 2015Research and Development, Sales and Marketing Merck, dynavax, keytruda
Merck is continuing to investigate Keytruda combinations as it signs a deal to test the drug with an immunotherapy from …
Perrigo buys OTC products from GSK
June 3, 2015Sales and Marketing GSK, GlaxoSmithKline, Mylan, Perrigo, Teva, brett wells
In an all-cash move with no financial details disclosed Perrigo is buying a portfolio of leading over-the-counter products from GlaxoSmithKline. …
Clark Health Communications hires three
June 3, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clark Health Communications
Clark Health Communications (CHC) has announced the hire of three new team members. The UK, London-based firm has recently welcomed …
NICE: people should be more involved in medical decisions
June 2, 2015Sales and Marketing NHS, NICE, medicines, optimisation
Around 15 million people in England now have at least one long-term condition, but figures suggest that as many as …
Bayer and Gilead expand in manufacturing
June 2, 2015Manufacturing and Production, Sales and Marketing Bayer, Gilead, brett wells, manufacturing
Both Bayer and Gilead are investing heavily into their manufacturing operations with expansion plans being laid down in Indonesia and …
NICE signs-off Roche’s Gazyvaro for leukaemia
June 2, 2015Sales and Marketing Allergan, Bayer, CLL, Carole Longson, Eylea, Gazyvaro, NICE, Ozurdex, Roche, diabetic macular edema, leukaemia
NICE has given positive final guidance backing the use of Roche’s Gazyvaro for people with chronic lymphocytic leukaemia (CLL). Earlier …
Mylan tells Teva to ‘stop playing games’ and make firm bid
June 2, 2015Manufacturing and Production, Sales and Marketing M&A, MA, Mylan, Teva, generics
Mylan has written another strongly-worded letter to Teva, this time accusing the Israeli firm of ‘playing games’ and violating US …
Amgen hires head of Europe from Roche
June 2, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Corinne Le Goff, Roche
Corinne Le Goff is joining Amgen to be its senior vice president and head of the European region for the …
NICE Lynparza rejection labelled ‘hard to understand’
June 2, 2015Sales and Marketing AstraZeneca, NICE, lynparza, olaparib
AstraZeneca has appealed to the government to put ‘urgent transitional measures’ in place to make sure patients can access innovative …
AstraZeneca lung drug shines on
June 1, 2015Sales and Marketing ASCO, AZD9291, AstraZeneca, MEDI4736, NSCLC, Tafinlar
AstraZeneca’s investigational drug AZD9291 is continuing to impress, with results announced at cancer conference ASCO building on its previous ‘unprecedented’ …
Latest content
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
